Inflammatory mediators in the development and progression of benign prostatic hyperplasia.
Benign prostatic hyperplasia (BPH) is the most common urological disease in elderly men. Epidemiological data suggest a causal link between this condition and prostatic inflammation. The prostate is an immune-competent organ characterized by the presence of a complex immune system. Several stimuli, including infectious agents, urinary reflux, metabolic syndrome, the ageing process, and autoimmune response, have been described as triggers for the dysregulation of the prostatic immune system via different molecular pathways involving the development of inflammatory infiltrates. From a pathophysiological standpoint, subsequent tissue damage and chronic tissue healing could result in the development of BPH nodules.
Department of Urology, Sant'Andrea Hospital, 'Sapienza' University of Rome, Via di Grottarossa 1035-1039, 00189, Rome, Italy.
Cosimo
C
De Nunzio
Department of Urology, Sant'Andrea Hospital, 'Sapienza' University of Rome, Via di Grottarossa 1035-1039, 00189, Rome, Italy.
Fabrizio
F
Presicce
Department of Urology, Sant'Andrea Hospital, 'Sapienza' University of Rome, Via di Grottarossa 1035-1039, 00189, Rome, Italy.
Andrea
A
Tubaro
D000818:Animals; D018450:Disease Progression; D006801:Humans; D007111:Immunity, Cellular / Q000502:physiology; D007249:Inflammation / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism; D018836:Inflammation Mediators / Q000378:metabolism*; D008297:Male; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism*
D018836:Inflammation Mediators
Prostate. 2003 Aug 1;56(3):171-82
12772186
Cancer Res. 2007 Feb 1;67(3):1378-84
17264317
Trends Immunol. 2006 Jan;27(1):17-23
16290228
Eur Urol. 2011 Dec;60(6):1173-80
21802828
Int J Mol Sci. 2013 Jul 10;14(7):14301-20
23846725
Eur Urol. 2014 Oct;66(4):619-22
25012523
Prostate. 2015 Mar 1;75(4):381-9
25451715
Asian J Androl. 2012 Mar;14(2):316-9
22157983
BJU Int. 2004 Jun;93(9):1241-5
15180615
Am J Pathol. 2015 Mar;185(3):870-82
25700986
Prostate. 2013 Jun;73(8):789-800
23620238
Prostate. 2015 Dec;75(16):1857-67
26306400
Am J Pathol. 2013 Jun;182(6):1942-9
23570837
J Endocrinol Invest. 2013 Apr;36(4):211-5
22733212
Urology. 2014 Nov;84(5):1181-7
25443931
Lab Invest. 2003 Aug;83(8):1131-46
12920242
Prostate. 2002 Jun 1;52(1):43-58
11992619
Am J Pathol. 2000 Jul;157(1):249-55
10880394
Differentiation. 2013 Apr-Jun;85(4-5):140-9
23792768
Eur Urol. 2003 Nov;44(5):549-55
14572753
Am J Clin Nutr. 2002 Apr;75(4):689-97
11916755
Res Rep Urol. 2012 Dec 31;5:1-10
24400229
Prostate. 2009 Dec 1;69(16):1774-80
19670242
J Inflamm (Lond). 2015 May 17;12:37
25991911
J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1
17632164
BJU Int. 2008 May;101(9):1111-8
18279447
J Urol. 1981 Apr;125(4):509-15
7012386
Prostate. 2004 Jul 1;60(2):153-9
15162381
Prostate. 2004 Sep 15;61(1):60-72
15287094
Int Braz J Urol. 2014 May-Jun;40(3):356-66
25010301
J Clin Epidemiol. 2001 Sep;54(9):935-44
11520654
Curr Opin Urol. 2006 Jan;16(1):25-9
16385197
Nature. 2006 Mar 9;440(7081):237-41
16407889
Eur Urol. 2011 Oct;60(4):691-8
21705134
BJU Int. 2003 Mar;91(4):409-16
12603425
Med Hypotheses. 2008;70(5):1021-3
17935901
Nat Rev Urol. 2016 Feb;13(2):108-19
26754190
Nat Rev Urol. 2014 Jul;11(7):369-70
24980193
Prostate. 2015 Apr 1;75(5):449-62
25560177
J Urol. 2005 Mar;173(3):1004-10
15711366
Prostate. 2014 Apr;74(4):337-45
24446128
Int J Obes (Lond). 2010 Sep;34(9):1396-403
20404829
BJU Int. 2012 Jul;110(2):274-82
22145816
J Immunol. 2009 Apr 1;182(7):4056-64
19299703
Mediators Inflamm. 2014;2014:397815
24808637
Cancer. 2003 Oct 15;98(8):1727-34
14534890
Eur Urol. 2007 May;51(5):1202-16
17182170
Urology. 2015 Aug;86(2):359-65
26194294
Nat Rev Urol. 2013 Jan;10(1):49-54
23165396
Prostate. 2012 Feb;72(3):233-43
21604287
Prostate. 2014 May;74(6):590-601
24615654
Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):15-24
16642253
BJU Int. 2007 Aug;100(2):327-31
17617139
Prostate. 2011 Nov;71(15):1701-9
21446005
Prostate. 2014 May;74(6):669-79
24500928
Eur Urol. 2005 Aug;48(2):277-83; discussion 283-4
15964132
Eur Urol. 2013 Oct;64(4):610-21
23711541
Nat Rev Cancer. 2007 Apr;7(4):256-69
17384581
J Urol. 2015 Aug;194(2):454-61
25828974
Am J Clin Nutr. 2007 Feb;85(2):523-9
17284753
Eur Urol. 2012 Mar;61(3):560-70
22119157
Prostate. 2007 Jul 1;67(10):1070-80
17474076
Eur Urol. 2007 Oct;52(4):964-72
17618043
J Endocrinol. 2012 Jul;214(1):31-43
22562653
Int J Androl. 2010 Jun 1;33(3):475-88
19508330
Eur Urol. 2008 Dec;54(6):1379-84
18036719
Br J Pharmacol. 2012 Sep;167(1):95-108
22471974
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):689-93
17241782
BJU Int. 2006 Apr;97 Suppl 2:7-11; discussion 21-2
16507046
Prostate Cancer Prostatic Dis. 2013 Mar;16(1):101-6
23165431
BJU Int. 2012 Oct;110(7):1050-9
22429766
Urology. 2004 Sep;64(3):504-9
15351580
Inflammation. 2012 Jun;35(3):1113-8
22189868
Eur Urol. 2015 Feb;67(2):271-2
25457016
Clin Biochem. 2014 Jul;47(10-11):909-15
24560954
Am J Clin Exp Urol. 2013 Dec 25;1(1):3-11
25110720
Prostate. 2010 Apr 1;70(5):473-81
19902472
J Androl. 1998 Jul-Aug;19(4):428-33
9733145
Int J Urol. 2014 Mar;21(3):308-12
23980666
BJU Int. 2012 Aug;110(3):401-7
22176817
Korean J Urol. 2010 Apr;51(4):266-70
20428430
Urology. 2015 Jan;85(1):274.e1-8
25444635
BJU Int. 2012 Apr;109(8):1194-7
21851551
Am J Epidemiol. 2008 Apr 15;167(8):925-34
18263602
Eur Urol. 2008 Jun;53(6):1228-35
18358592
Prostate. 2013 Sep;73(13):1391-402
23765639
Prostate. 2004 Feb 1;58(2):121-9
14716737
Am J Epidemiol. 2006 Oct 15;164(8):760-8
16905643
Urology. 2008 Jul;72(1):205-13
18314176
BJU Int. 2013 Feb;111(2):304-11
23356748
J Biol Chem. 2012 May 25;287(22):18376-85
22474290
BJU Int. 2011 Jul;108(2 Pt 2):E23-8
20840324
Int J Androl. 2011 Dec;34(6 Pt 1):600-13
20969602
BJU Int. 2013 Aug;112(4):432-41
23650937
Eur Urol. 2006 Sep;50(3):549-54
16442205
Eur Urol. 2011 Jul;60(1):106-17
21497433
Prostate Cancer Prostatic Dis. 2016 Mar;19(1):7-13
26391088
Biochim Biophys Acta. 2013 Jan;1832(1):183-94
22986049